Cathay Biotech

Cathay Biotech EBITDA per Share

The EBITDA per Share of Cathay Biotech (688065.SS) as of Oct 18, 2026 is 0.90 CNY. In the previous year, EBITDA per Share was 1.08 CNY — a change of -16.76% (lower).

EBITDA per Share

0.90CNY

YoY

-16.76%

Last updated:

EBITDA per Share of Cathay Biotech is 2025 0.90 CNY. EBITDA per Share of Cathay Biotech was 2024 1.08 CNY. It decreases by -16.76% lower compared to the previous year.

The Cathay Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.80 CNY
Jan 1, 2019
1.17 CNY
Jan 1, 2020
0.95 CNY
Jan 1, 2021
1.29 CNY
Jan 1, 2022
1.36 CNY
Jan 1, 2023
0.86 CNY
Jan 1, 2024
1.08 CNY
Jan 1, 2025
0.90 CNY
The Cathay Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
0.90CNY-16.76%
1.08CNY+24.57%
0.86CNY-36.41%
1.36CNY+5.68%
1.29CNY+35.33%
0.95CNY-18.99%
1.17CNY+46.91%
0.80CNY+35.94%
0.59CNY+103.02%
0.29CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cathay Biotech Stock analysis

What does Cathay Biotech do? Cathay Biotech Inc., headquartered in Shanghai, China, operates in the Materials sector with a focus on Chemicals. The company develops, produces, and sells new bio-based materials, including biological long-chain dibasic acids and bio-based polyamide series such as lauric acid and brazilian acid. These products are utilized in long-chain polyamides, fragrances, hot melt adhesives, lubricants, and powder coatings. Cathay Biotech serves both domestic and international markets with a workforce of 2,324 employees, having listed on the stock market in 2020. Cathay Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cathay Biotech stock

EBITDA per Share of Cathay Biotech is 0.90 CNY in 2025.

EBITDA per Share of Cathay Biotech changed from 1.08 CNY to 0.90 CNY, representing a -16.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Cathay Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cathay Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cathay Biotech